OBJECTIVES: Kidney stones affect nearly one in 11 persons in the United States, and among those experiencing symptoms, emergency care is common. In this population, little is known about the incidence of and factors associated with repeat emergency department (ED) visits. The objective was to identify associations between potentially mutable factors and the risk of an ED revisit for patients with kidney stones in a large, all-payer cohort. METHODS: This was a retrospective cohort study of all patients in California initially treated and released from EDs for kidney stones between February 2008 and November 2009. A multivariable regression model was created to identify associations between patient-level characteristics, area health care resources, processes of care, and the risk of repeat ED visits. The primary outcome was a second ED visit within 30 days of the initial discharge from emergent care. RESULTS: Among 128,564 patients discharged from emergent care, 13,684 (11%) had at least one additional emergent visit for treatment of their kidney stone. In these patients, nearly one in three required hospitalization or an urgent temporizing procedure at the second visit. On multivariable analysis, the risk of an ED revisit was associated with insurance status (e.g., Medicaid vs. private insurance; odds ratio [OR] = 1.52, 95% confidence interval [CI] = 1.43 to 1.61; p < 0.001). Greater access to urologic care was associated with lower odds of an ED revisit (highest quartile OR = 0.88, 95% CI = 0.80 to 0.97; p < 0.01 vs. lowest quartile). In exploratory models, performance of a complete blood count was associated with a decreased odds of revisit (OR = 0.86, 95% CI = 0.75 to 0.97; p = 0.02). CONCLUSIONS: Repeat high-acuity care affects one in nine patients discharged from initial emergent evaluations for kidney stones. Access to urologic care and processes of care are associated with lower risk of repeat emergent encounters. Efforts are indicated to identify preventable causes of ED revisits for kidney stone patients and design interventions to reduce the risk of high-cost, high-acuity, repeat care.
OBJECTIVES:Kidney stones affect nearly one in 11 persons in the United States, and among those experiencing symptoms, emergency care is common. In this population, little is known about the incidence of and factors associated with repeat emergency department (ED) visits. The objective was to identify associations between potentially mutable factors and the risk of an ED revisit for patients with kidney stones in a large, all-payer cohort. METHODS: This was a retrospective cohort study of all patients in California initially treated and released from EDs for kidney stones between February 2008 and November 2009. A multivariable regression model was created to identify associations between patient-level characteristics, area health care resources, processes of care, and the risk of repeat ED visits. The primary outcome was a second ED visit within 30 days of the initial discharge from emergent care. RESULTS: Among 128,564 patients discharged from emergent care, 13,684 (11%) had at least one additional emergent visit for treatment of their kidney stone. In these patients, nearly one in three required hospitalization or an urgent temporizing procedure at the second visit. On multivariable analysis, the risk of an ED revisit was associated with insurance status (e.g., Medicaid vs. private insurance; odds ratio [OR] = 1.52, 95% confidence interval [CI] = 1.43 to 1.61; p < 0.001). Greater access to urologic care was associated with lower odds of an ED revisit (highest quartile OR = 0.88, 95% CI = 0.80 to 0.97; p < 0.01 vs. lowest quartile). In exploratory models, performance of a complete blood count was associated with a decreased odds of revisit (OR = 0.86, 95% CI = 0.75 to 0.97; p = 0.02). CONCLUSIONS: Repeat high-acuity care affects one in nine patients discharged from initial emergent evaluations for kidney stones. Access to urologic care and processes of care are associated with lower risk of repeat emergent encounters. Efforts are indicated to identify preventable causes of ED revisits for kidney stonepatients and design interventions to reduce the risk of high-cost, high-acuity, repeat care.
Authors: Glenn M Preminger; Hans-Göran Tiselius; Dean G Assimos; Peter Alken; Colin Buck; Michele Gallucci; Thomas Knoll; James E Lingeman; Stephen Y Nakada; Margaret Sue Pearle; Kemal Sarica; Christian Türk; J Stuart Wolf Journal: J Urol Date: 2007-12 Impact factor: 7.450
Authors: John M Hollingsworth; Mary A M Rogers; Samuel R Kaufman; Timothy J Bradford; Sanjay Saint; John T Wei; Brent K Hollenbeck Journal: Lancet Date: 2006-09-30 Impact factor: 79.321
Authors: Charles D Scales; Tracey L Krupski; Lesley H Curtis; Brian Matlaga; Yair Lotan; Margaret S Pearle; Christopher Saigal; Glenn M Preminger Journal: J Urol Date: 2011-05-14 Impact factor: 7.450
Authors: Anobel Y Odisho; Matthew R Cooperberg; Vincent Fradet; Ardalan E Ahmad; Peter R Carroll Journal: J Clin Oncol Date: 2010-04-20 Impact factor: 44.544
Authors: Charles D Scales; Julie C Lai; Andrew W Dick; Jan M Hanley; Jeroen van Meijgaard; Claude M Setodji; Christopher S Saigal Journal: JAMA Surg Date: 2014-07 Impact factor: 14.766
Authors: Pamela K Burrows; Judd E Hollander; Allan B Wolfson; Michael C Kurz; Lorna Richards; Sara DiFiore; Phillip Watts; Nivedita Patkar; Jeremy Brown; Stephen Jackman; Ziya Kirkali; John W Kusek; Chloe Michel; Andrew C Meltzer Journal: Contemp Clin Trials Date: 2016-11-23 Impact factor: 2.226
Authors: Charles D Scales; Gregory E Tasian; Andrew L Schwaderer; David S Goldfarb; Robert A Star; Ziya Kirkali Journal: Clin J Am Soc Nephrol Date: 2016-03-10 Impact factor: 8.237
Authors: Andrew C Meltzer; Pamela Katzen Burrows; Allan B Wolfson; Judd E Hollander; Michael Kurz; Ziya Kirkali; John W Kusek; Patrick Mufarrij; Stephen V Jackman; Jeremy Brown Journal: JAMA Intern Med Date: 2018-08-01 Impact factor: 21.873
Authors: Charles D Scales; Jonathan Bergman; Stacey Carter; Gregory Jack; Christopher S Saigal; Mark S Litwin Journal: Urology Date: 2015-09-01 Impact factor: 2.649
Authors: William D Brubaker; Kai B Dallas; Christopher S Elliott; Alan C Pao; Glenn M Chertow; John T Leppert; Simon L Conti Journal: J Endourol Date: 2018-11-16 Impact factor: 2.942
Authors: Jonathan D Harper; Bryan W Cunitz; Barbrina Dunmire; Franklin C Lee; Mathew D Sorensen; Ryan S Hsi; Jeff Thiel; Hunter Wessells; James E Lingeman; Michael R Bailey Journal: J Urol Date: 2015-10-30 Impact factor: 7.450
Authors: Jane T Kurtzman; Lihai Song; Michelle E Ross; Charles D Scales; David I Chu; Gregory E Tasian Journal: J Urol Date: 2018-02-21 Impact factor: 7.450